Céspedes MA, Castellanos SG

Language: Spanish
References: 20
Page: 1576-1583
PDF size: 75.11 Kb.

ABSTRACT

A descriptive, observational study, of retrospective cohort was carried out in 90 operated patients for colorectal cancer with curative aims, who had been attended in the Coloproctology Service of "Dr. Ambrosio Grillo Portuondo" University Hospital in Santiago de Cuba, from January, 1993 to December, 2003, with the objective of determining their survival, for which the method of Kaplan-Meier estimate was applied. Among the relevant results there were the female sex and the age older than 60 years; it was also observed that the patients operated for this cause survived an average of 5 year, with variations not far from the world statistics, according to the clinical and epidemiological variables selected.

REFERENCES

1. Vincent T, De Vita VT, Lawrence TS. De Vita, Hellman and Rosenberg's Cancer Principles and Practice. 6 ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

2. Cáncer de colon. ¿Cómo diagnosticarlo? [citado 12 Jun 2013].

3. González Contreras QH, Bahena Aponte JA. Cáncer de colon. Rev Gastroenterol Méx. 2010; Supl.1 (75): 65-8.

4. Benson AB, Bekaii-Saab T, Chan E, Yi-Jen C, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer [citado 12 Jun 2013].

5. Bannura G, Cumsille MA. Estimación de la supervivencia en pacientes operados por cáncer de colon: método de Kaplan-Meier. Rev Chilena Cir. 2004; 56(3): 263-8.

6. Machado Pineda M, Rodríguez Fernández Z, González Tuero JH, Rodríguez Ramírez R. Relación diagnóstico y supervivencia en el cáncer de colon. MEDISAN. 2011 [citado 12 Jun 2013]; 15(11).

7. Kozak KR, Moody JS. The impact of T and N stage on long-term survival of rectal cancer patients in the community. J Surg Oncol. 2008; 98(3): 161-6.

8. Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cuniningham D, et al. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress al Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol. 2008; 19(Suppl 6): 1-8.

9. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Yunghui-Vivien L, et al. Method of recommendation for colorectal cancer screening strategies impacts adherence. Gastroenterology. 2010; 138(5 Suppl 1): 23.

10. Instituto nacional del Cáncer. Cáncer de colon [citado 12 Jun 2013].

11. Bestes Ibáñez M, Muñoz Nava M. Factores pronósticos del cáncer colorrectal. An Med Interna (Madrid). 2008 [citado 12 Jun 2013]; 25(7).

12. Decanini-Terán CO, González-Acosta J, Obregón Méndez J, Vega-de Jesús M. Cáncer de recto. Diagnóstico, estadificación y tratamiento. Cir Cir. 2011; 79(5): 481-7.

13. Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria, Centro Cochrane Iberoamericano. Guía de práctica clínica. Actualización 2009. Prevención del cáncer colorrectal. 4. Barcelona: Elsevier [citado 12 Jun 2013]; 2009.

14. Engstrom PF, Arnoletti JP, Benson AB, Yi-Jen C, Choti A, Cooper HS, et al. A National Comprehensive Cancer Network. Rectal Cancer. Clinical Practice Guidelines in Oncology –VI 2010. J Natl Compr Canc Netw. 2009; 7: 838-81.

15. Marzo M, Bellas B, Melús E, Nuin M, Vela C, Vilarrubí M. Prevención del Cáncer Colorrectal. Rev Clin Med Fam. Albacete. 2010 [citado 12 Jun 2013]; 3(2).

16. Razzak A, Oxentenko AS, Vierkant RA, Tillmans LS, Wang A, Weisenberger DJ, et al. Diabetes mellitus (DM) and colorectal Cancer (CRC) risk by molecularly-defined subtypes in a prospective study of older women. Gastroenterology. 2010; 138(5 Suppl 1): 28.

17. Siddiqui A, Chang M, Mahgoub A, Pena Sahdala HN. Increase in body size is associated with an increased incidence of advanced adenomatous colon polyps in male veteran patients. Digestion. 2011; 83(4): 288-90.

18. Takeuchi H, Katajima M, Kitagawa Y. Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local inmunoresponse to malignant cells. Cancer Sci. 2008; 99(3): 441-50.

19. Unbarrena-Amrzaga R, Ortego J, Fuentes J, Raventos N, Parra P, Uribarrena Echevarría R. Valor pronóstico de las micrometástasis lifoganglionares en pacientes con cáncer colorrectal en estadios A y B de Dukes (T1-T4, N0, M0). Rev Esp Enferm Dig. 2010 [citado 12 Jun 2013]; 102(3).

20. Pendyala S, Holt P. Weight loss reduces rectosigmoid inflammation in obesityimplications for colorectal cancer pathogenesis and prevention. Gastroenterology. 2010; 138(5 Suppl 1): 28.